Verily

Business By Charles Piller

Autofocus contact lens being developed by Verily and Alcon suffers delay

Business By Rebecca Robbins

New diabetes tech is coming. But will it make much difference?

Health By Sharon Begley

Scientist using big data against heart disease wins $75 million award

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Teva expects FDA to speed review of its generic EpiPen

Pharmalot By Ed Silverman

Q&A: Glaxo exec says bioelectronics venture with Verily is ‘not science fiction’

Business By Stephanie Simon

Google spinoff teams with pharma giant to treat disease by zapping nerves

Biotech By Charles Piller

Top exec defends Google biotech spinoff, promises ‘amazing’ breakthroughs

Special Report By Charles Piller

‘Silicon Valley arrogance’? Google misfires as it strives to turn Star Trek fiction into reality